Medine.co.uk

Out of date information, search another

Diasleep Plus Tablets

Out of date information, search another
Informations for option: Diasleep Plus Tablets, show other option

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

DiaSleep Plus tablets

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Each coated tablet contains:

125 mg of extract (as dry extract) from Valerian root (Valeriana officinalis L.) (3-6:1) (equivalent to 375 - 750 mg of Valerian root).

Extraction solvent: Ethanol 70% v/v,

and

250 mg of extract (as dry extract) from Passion flower herb (Passiflora incarnata L.) (5-7:1) (equivalent to 1250 - 1750 mg of Passion flower herb).

Extraction solvent: Ethanol 50% v/v

Excipients: each coated tablet contains 187 mg of sucrose and 32 mg of glucose.

For full list of excipients, see section 6.1

3 PHARMACEUTICAL FORM

Coated tablet.

Light-yellow, round, biconvex, smooth glossy surface.

4


CLINICAL PARTICULARS

4.1 Therapeutic indications

A traditional herbal medicinal product used for the temporary relief of sleep disturbances due to symptoms of mild anxiety, based on traditional use only.

4.2 Posology and method of administration

For oral short term use only.

For adults and the elderly, take one to two tablets half an hour before bedtime. Tablets should be swallowed whole with some water or other liquid. The tablets should not be chewed.

As treatment effects may not be apparent immediately, DiaSleep Plus should be taken for at least 2 weeks continuously.

If symptoms worsen or do not improve after 4 weeks a doctor or qualified healthcare practitioner should be consulted.

Not for children or adolescents under 18 years.

4.3 Contraindications

Hypersensitivity to Valerian, Passion Flower or any of the excipients in the product. The product should not be used in children or adolescents under 18 years.

4.4 Special warnings and precautions for use

Do not exceed the stated dose.

This product contains sucrose and glucose.

1 sugar-coated tablet contains max. 187 mg of sucrose and a max. 32 mg glucose.

Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine

4.5 Interaction with other medicinal products and other forms of interaction

Only limited data on pharmacological interactions with other medicinal products are available. Additive effects with hypnotics and other sedative drugs cannot be excluded and therefore co-medication is not recommended as a general precaution.

The effect of DiaSleep Plus may be potentiated by alcohol. Excessive concomitant consumption of alcohol should therefore be avoided.

4.6 Fertility, Pregnancy and lactation

The safety of the product during pregnancy and lactation has not been established. Therefore it should be avoided during pregnancy or lactation.

4.7 Effects on ability to drive and use machines

May impair the ability to drive and use machines. If affected, do not drive or operate machines.

4.8 Undesirable effects

Gastrointestinal symptoms, such as nausea, abdominal cramps, may occur. The frequency is not known. One case of hypersensitivity (vasculitis) and one case of tachycardia have been reported with Passion Flower. The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or qualified healthcare practitioner should be consulted.

4.9 Overdose

Valerian root at a dose of approximately 20 g (equivalent to 10 tablets) caused benign symptoms (fatigue, abdominal cramp, chest tightness, lightheadedness, hand tremor and mydriasis), which disappeared within 24 hours. If symptoms arise, treatment should be supportive.

After intake of very high doses of Valerian root over several years (daily consumption corresponding to approximately 30 g of the drug) withdrawal symptoms (delirium) have been reported.

No cases of overdose have been reported for Passion Flower.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not applicable.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

The preclinical toxicology data available are limited. Tests on reproductive toxicity, genotoxicity and carcinogenicity have not been performed.

6    PHARMACEUTICAL PARTICULARS

6.1    List of excipients

Tablet core

Maltodextrin

Silica, colloidal anhydrous Cellulose, powdered Croscarmellose sodium Magnesium stearate Stearic acid Talc

Liquid glucose, spray dried

Coating

Sucrose

Talc

Calcium carbonate E170

Acacia

Tragacanth

Titanium dioxide E 171

Liquid glucose, spray dried

Iron oxide hydrate E 172 (=yellow iron oxide)

Hypromellose

Capol 600 T.S. containing:

Beeswax, white Camauba wax Shellac

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

The shelf life is 4 years

6.4 Special precautions for storage

Do not store above 30°C.

6.5 Nature and contents of container

Original packages contain 30, 60, 90 or 100 coated tablets

DiaSleep plus coated tablets are packed in PVC/ PVDC- aluminium blisters and inserted into a carton.

6.6 Special precautions for disposal

No special requirements

7 MARKETING AUTHORISATION HOLDER

Diapharm GmbH & Co. KG Hafenweg 18-20 48155 Munster Germany

8    MARKETING AUTHORISATION NUMBER(S)

THR 42340/0004

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

22/12/2008

10 DATE OF REVISION OF THE TEXT

29/07/2013